These findings suggest that GLP-1RAs may have beneficial effects on cardiovascular outcomes and coronary artery disease progression in this population
Yes, but it's a rare phenomenon
[26], and Adeniran et al
Modern therapeutic options include intratendinous injections of substances believed to inhibit neovascularization, such as corticosteroids (which can cause collagen sclerosis and long-term damage to the tendon), or of substances that relieve pain by other pathways (acupuncture, extracorporeal shock wave therapy [ESWT]) or that stimulate tendon repair (platelet-rich plasma [PRP]) [12,13,14,15]
Bottom line: MeAgain is a tracking and education app, not a clinical service
It was a randomized, double-blinded, noninferiority placebo-controlled trial evaluating the cardiovascular safety of Ozempic vs